医疗设备制造商Revvity（RVTY）周一盘前股价大跌10.31%，主要原因是公司下调了2025年全年利润预期。
根据公司最新发布的财报，Revvity将2025年调整后每股收益预期从此前的4.90美元至5.00美元下调至4.85美元至4.95美元。公司表示，预计一些国际市场对其诊断产品的需求仍将疲软，特别是在中国市场。数据显示，Revvity在中国的诊断产品销售额在第二季度出现两位数下降。
尽管Revvity公布的第二季度业绩好于预期，调整后每股收益为1.18美元，高于分析师预期的1.14美元，但投资者似乎更关注公司未来的盈利前景。值得注意的是，Revvity上调了全年营收预期，从此前的28.3亿至28.7亿美元上调至28.4亿至28.8亿美元，部分原因是美元走软。然而，这一积极因素并未能抵消利润预期下调带来的负面影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.